CN104173628B - 一种抗猪免疫抑制的中药组合物 - Google Patents
一种抗猪免疫抑制的中药组合物 Download PDFInfo
- Publication number
- CN104173628B CN104173628B CN201410391670.0A CN201410391670A CN104173628B CN 104173628 B CN104173628 B CN 104173628B CN 201410391670 A CN201410391670 A CN 201410391670A CN 104173628 B CN104173628 B CN 104173628B
- Authority
- CN
- China
- Prior art keywords
- pig
- chinese medicine
- medicine composition
- immunosuppressive
- rascal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 13
- 230000001506 immunosuppresive effect Effects 0.000 title claims description 12
- 235000019640 taste Nutrition 0.000 claims abstract description 11
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 7
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 7
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 7
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 7
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 7
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 7
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 7
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 7
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 7
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 7
- 239000009636 Huang Qi Substances 0.000 claims abstract description 7
- 241000334160 Isatis Species 0.000 claims abstract description 7
- 241000218378 Magnolia Species 0.000 claims abstract description 7
- 244000197580 Poria cocos Species 0.000 claims abstract description 7
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 7
- 241000132012 Atractylodes Species 0.000 claims abstract description 6
- 235000018905 epimedium Nutrition 0.000 claims abstract description 6
- 241000424773 Epimedium alpinum Species 0.000 claims abstract description 5
- 241001092040 Crataegus Species 0.000 claims description 6
- 201000010099 disease Diseases 0.000 abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 20
- 230000036737 immune function Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 230000000947 anti-immunosuppressive effect Effects 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 description 66
- 208000011580 syndromic disease Diseases 0.000 description 13
- 229960005486 vaccine Drugs 0.000 description 10
- 208000032625 disorder of ear Diseases 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 241001071864 Lethrinus laticaudis Species 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 208000009305 pseudorabies Diseases 0.000 description 3
- 208000023504 respiratory system disease Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 206010020843 Hyperthermia Diseases 0.000 description 2
- 206010065673 Nephritic syndrome Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 241001661006 Pepper cryptic virus 2 Species 0.000 description 2
- 241000202347 Porcine circovirus Species 0.000 description 2
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000036031 hyperthermia Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 229940125721 immunosuppressive agent Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000195622 Astasia Species 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000005753 Circoviridae Infections Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001016310 Epimedium grandiflorum Species 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000019802 Sexually transmitted disease Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- AHIZUOHBPONPMB-UHFFFAOYSA-N [Na].O1C=CC=C1 Chemical compound [Na].O1C=CC=C1 AHIZUOHBPONPMB-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229960003760 florfenicol Drugs 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种抗猪免疫抑制的中药组合物,由下列重量百分比的各味中药制成:淫羊藿8~16%,板兰根8~16%,黄芪10~26%,白术8~15%,茯苓8~15%,泽泻5~15%,陈皮5~15%,青皮4~8%,厚朴4~8%,山楂4~8%,甘草补足至100%。本发明不仅能够提高猪的免疫功能,预防各种疾病的发生,而且能提高猪的各种生产性能指标。
Description
技术领域
本发明涉及一种中兽药,具体为一种抗猪免疫抑制的中药组合物。
背景技术
随着国民经济发展,居民生活水平的提高,肉类消费逐年增长,其中,猪肉消费占肉类消费的60-70%,进一步促进养猪业向规模化、专业化发展。但因技术、资金、环保等条件的制约,使得猪场设施设备及技术人员的缺乏,致使疾病的频繁发生,导致抗生素及微量元素的过度添加,从而引发猪肉食品的安全问题。
免疫抑制是免疫抑制因素损伤免疫组织器官或影响免疫细胞活性,干扰抗原的递呈,抑制或阻断免疫抗体形成等途径,导致机体抗病能力的下降或免疫应答不全,造成动物对病原的高度敏感而易发生疾病。免疫抑制因素主要包括有:免疫抑制性传染病、环境因素和管理不善引起的应激、滥用抗生素和饲料霉菌毒素等。
免疫抑制性传染病毒主要有猪蓝耳病毒(PRRSV)和猪圆环病毒Ⅱ型(PCV-2)等病毒和其它病原体。猪蓝耳病毒(PRRSV)嗜好在肺内的免疫细胞-巨噬细胞内复制和增殖,使巨噬细胞破解、溶解、崩溃和数量减少,引起免疫功能下降,继发感染多种病原体。而猪圆环病毒Ⅱ型(PCV-2)感染后同样引起淋巴细胞调亡,引起免疫功能下降。因这两种病毒的感染,在2007年暴发了全国性的“猪高热病”。由于这两种病毒或其它病毒流行时,及环境和管理因素的影响,包括饲养管理、气候因素、环境条件等,归纳为温度、湿度、密度、清洁度、舒适度等对猪的不适应,而产生强烈应激,使抗病力下降,各种疫苗免疫抗体水平低下,甚至无免疫抗体产生,而暴发多种综合征,如呼吸障碍综合征、繁殖障碍综合征、新生仔猪腹泻综合征、断奶仔猪系统衰竭综合征、皮炎-肾炎综合征、胃肠道功能紊乱综合征等。这种状况如不能控制,必然会加大抗生素使用频率和用量,加重细菌的耐药性和抗生素的残留量,严重影响养猪的经济效益,制约养猪业的发展。
目前解决猪免疫抑制的措施和技术主要有:改善猪栏环境条件并加强饲养管理等措施,如水帘降温设施的环控猪栏等;饲料中添加益生菌、维生素,根据季节变化在饲料中添加不同中兽药或中兽药提取物,及免疫球蛋白,白细胞介素,干扰素等生物制剂的应用。这些措施和技术在抗免疫抑制方面有很好的效果,但在使用成本、使用方法等方面有一定的局限性。
发明内容
本发明所要解决的技术问题是提供一种能够有效地消除猪的应激反应,缓解其免疫抑制作用,提高其免疫功能和各种生产性能指标,预防各种疾病的发生,且不易产生抗药性的中药组合物。
本发明解决上述技术问题所采取的技术方案是:一种抗猪免疫抑制的中药组合物,由下列重量百分比的各味中药制成:淫羊藿8~16%,板兰根8~16%,黄芪10~26%,白术8~15%,茯苓8~15%,泽泻5~15%,陈皮5~15%,青皮4~8%,厚朴4~8%,山楂4~8%,甘草补足至100%。
所述的抗猪免疫抑制的中药组合物,优选下列重量百分比的各味中药制成:淫羊藿12%,板兰根13%,黄芪16%,白术10%,茯苓10%,泽泻8%,陈皮8%,青皮6%,厚朴6%,山楂6%,甘草5%。
所述的抗猪免疫抑制的中药组合物使用方法是:
(1)用作预防:按重量百分比称取上述中药原料,粉碎成60目细粉,按0.5%(wt/wt)加入饲料中搅拌均匀,连用5~12天,停药7天,重复使用。或是颗粒饲料按每次日粮量的0.5%称取中药,用5倍量开水浸泡20~30分钟,待冷却后,将药液及药渣均匀拌入饲料中饲喂。
(2)用作治疗:按重量百分比称取上述中药原料,粉碎成60目细粉,按0.8-1.0%(wt/wt)加入饲料中搅拌均匀,连用5~12天,后按预防的用法用量预防。或是颗粒饲料按每次日粮量的1.0%称取中药,用5倍量开水浸泡20-30分钟,待冷却后,将药液及药渣均匀拌入饲料中饲喂。
本发明不仅能够提高猪的免疫功能,预防各种疾病的发生,而且能提高猪的各种生产性能指标。本发明具备的功效如下:扶正祛邪,清热解毒,健脾化湿,对以下症状具有预防保健的效果。
1.食欲差,肠道功能紊乱。精神不振,活力差,不爱动;猪眼角分泌物增多,常见有泪痕,眼结膜潮红。下痢,粪便臭味浓,有时粪便干硬、且少;尿少呈黄色,臊味浓。
2.猪生长缓慢,毛粗乱无光泽,个体间发育不均匀,同日龄同栏猪大小不一,体重差别大,出栏膘情差;
3.猪抗病力低,容易感染多种综合征。猪场发生下列一种或多种传染病,如母猪繁殖障碍,如不发情,屡配不上,产死胎,弱胎及哺乳仔猪死亡率高,母猪使用年限低、淘汰率高等;断奶仔猪多系统衰竭综合征,如进出保育栏的断奶仔猪和小猪厌食,消瘦虚弱,皮肤苍白,下痢或下水粪分离的粪便,咳嗽,呼吸困难,断奶仔猪死亡率在20%左右;肾炎-皮炎综合症,多为中小猪皮肤上出现圆形或不规则形的隆起或疖点,呈红色或暗紫色,重者长满全身,厌食,体重减轻,呼吸困难。温和型体温正常会自行康复;呼吸障碍综合征,多为继发副猪嗜血杆菌病,胸膜性肺炎等引起呼吸道症状等。
4.各种疫苗免疫后抗体效价,如猪瘟、蓝耳和伪狂犬等,合格率低于80%,疫苗免疫没有完全保护作用。
5.冷热或春夏秋冬季节变换的气候应激,及免疫、转栏、换料等各种应激易引发疾病的预防。
具体实施方式
中兽医学认为动物各腑脏组织之间,以及动物与外界环境之间,既对立又统一,维持着相对的动态平衡,从而保持着动物正常的生理和生产性能。当这种动态平衡因某种原因而遭受到破坏,又不能立即自行调节得以恢复时,动物就会发病。动物体内动态平衡遭受破坏的因素,包括外感六淫、疠气,七情内伤,饮食、劳逸等,尤其是外感风邪、热邪、暑邪、寒邪、疫疠,及恐、惊和过度使用抗生素等,至使猪正气不足,机体脏腑等功能衰退,抗御致病邪气能力低下。因此,治则为扶正祛邪,清热解毒,健脾化湿。即调节动物体内的相对动态平衡,以达“不治已病治未病”的预防疾病的目的。本发明组方中,黄芪补益脾、肺气,淫羊藿温补肾阳,白术健脾燥湿,茯苓健脾利水,四味扶正,健脾化湿,共培先天和后天之本为君药。板兰根清热解毒,泽泻渗湿,泄肾虚火,二味共清热解毒为臣。陈皮理气,防脾过实;厚朴行气以化痰湿,以防咳喘;青皮破气以荡涤肠腑,攻下热结,助肺宣降;山楂消食化积。四味以理气,行气,破气,化积助君药以达扶正祛邪为使。甘草调和诸药共奏扶正祛邪,清热解毒,健脾化湿之功效。
产品实例1
中药组方:淫羊藿12%,板兰根13%,黄芪16%,白术10%,茯苓10%,泽泻8%,陈皮8%,青皮6%,厚朴6%,山楂6%,甘草5%。
以上组方在猪场预防猪免疫抑制试验如下:
试验猪场为A猪场存栏猪370头,其中母猪63头,哺乳仔猪55头,小猪(4-14周龄)123头,中大猪(14周龄以上)129头。猪场按免疫程序分别免疫猪瘟,猪蓝耳病,猪伪狂犬,猪口蹄疫等疫苗。猪群健康状况如下:母猪3头发情配不上种,其中,1头尿中见白色沉淀物;2头已配种母猪返情;怀孕母猪多见眼角有泪痕或眼屎,眼结膜潮红;8头哺乳母猪中有5头泌乳少,乳房红肿或干瘪,哺乳仔猪消瘦,拉白色稀粪;保育猪(4~7周龄)有一栏24头,见瘦弱,毛乱无光泽,拉灰色稀粪便,呼吸困难,有的站立不稳,多数卧地不肯走动。其余5栏小猪每栏有1~3头有不同程度的呼吸困难,呈腹试呼吸,拉灰色稀粪。中大猪咳嗽或喘气,多呈腹式呼吸,每栏猪有1~3头皮肤长有红色疖点,疖点多者长满全身,亦见毛根有渗出铁锈色的猪,多数粪便不成形,或拉稀,且腥臭,尿少且黄有臊味。猪群中有疾病症状的猪用头孢塞呋钠注射治疗,全栏添加10%氟苯尼考散剂于饲料饲喂,病猪症状有缓解,但易反复。根据上述病症确诊为A猪场的猪处于免疫抑制。发病猪的病症分别为:母猪繁殖障碍综合征,仔猪系统衰竭综合征,中猪为皮炎-肾炎综合征或呼吸障碍综合征。
A猪场全部所有猪按上述中药组合物按日饲料量的0.5%添加,每个疗程7天,停7天,再重复循环使用,在连续使用三个疗程后,猪群中粪便成形,尿清,腥臭味、臊味未闻到,皮红润,毛光亮,少咳嗽声,母猪断奶后7天发情配种。检测猪瘟、猪蓝耳病、猪圆环病毒病,猪伪狂犬病的疫苗抗体,(猪圆环病疫苗没有免疫,检测出的抗体阳性为野毒感染结果),而B、C猪场和A猪场相邻900米内,B猪场猪存栏约1000头,C猪场猪存栏约1500头,B、C两个猪场的猪健康状况与A猪场的猪与未喂本发明中药前相似,也与2007年全国暴发“猪高热病”后普遍存在感染或隐性感染猪蓝耳病毒和猪圆环病毒等免疫抑制性病毒相似。疫苗免疫的种类及免疫程序和A猪场相同,用抗生素和中药治疗和预防。猪瘟、蓝耳病、伪狂犬病和圆环病的抗体检测时间同在一个月内,结果如下表。
猪群主要抗体检测阳性率 单位:%
从表中可看出:A猪场使用本发明中药组方后,猪免疫抑制得到了有效控制,所免疫的疫苗抗体阳性合格率都在80%以上(除2周龄仔猪蓝耳病和猪伪狂犬的母源抗体外,其多为疫苗的原因,蓝耳病疫苗的首次免疫在出生后12天左右。),而且,能有效抗猪圆环病毒的感染。
所述的抗猪免疫抑制的中药组合物同时能有效治疗猪蓝耳病毒、圆环病毒等感染引起的各种综合征,及其愈后生理及免疫等功能恢复的调理。
所述的抗猪免疫抑制的中药组合物在制备及使用过程中需要注意的是:
(1)本发明中药方剂粉碎成达60目以上细粉,而且越效果越好;
(2)本发明中药方剂的中药原料应无变质、发霉,水份含量在12%以下;
(3)本发明中药方剂制成后密封,保存于干燥,阴凉处。
Claims (2)
1.一种抗猪免疫抑制的中药组合物,其特征在于,由下列重量百分比的各味中药制成:淫羊藿8~16%,板兰根8~16%,黄芪10~26%,白术8~15%,茯苓8~15%,泽泻5~15%,陈皮5~15%,青皮4~8%,厚朴4~8%,山楂4~8%,甘草补足至100%。
2.根据权利要求1所述的抗猪免疫抑制的中药组合物,其特征在于,由下列重量百分比的各味中药制成:淫羊藿12%,板兰根13%,黄芪16%,白术10%,茯苓10%,泽泻8%,陈皮8%,青皮6%,厚朴6%,山楂6%,甘草5%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410391670.0A CN104173628B (zh) | 2014-08-11 | 2014-08-11 | 一种抗猪免疫抑制的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410391670.0A CN104173628B (zh) | 2014-08-11 | 2014-08-11 | 一种抗猪免疫抑制的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104173628A CN104173628A (zh) | 2014-12-03 |
CN104173628B true CN104173628B (zh) | 2017-10-27 |
Family
ID=51955152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410391670.0A Expired - Fee Related CN104173628B (zh) | 2014-08-11 | 2014-08-11 | 一种抗猪免疫抑制的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104173628B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435625B (zh) * | 2014-12-09 | 2018-02-27 | 广西壮族自治区药用植物园 | 一种减缓肉牛运输应激的复方中草药制剂及其制备方法 |
CN106038684A (zh) * | 2016-06-28 | 2016-10-26 | 江苏省农业科学院 | 一种防治猪圆环病毒病的中草药复方及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101112446A (zh) * | 2007-08-10 | 2008-01-30 | 邓世平 | 猪蓝耳病的治疗配方、制作方法及其药液使用方法 |
CN101869220A (zh) * | 2010-06-07 | 2010-10-27 | 浙江省农业科学院 | 防控猪高热综合征的中草药饲料添加剂 |
CN102688417A (zh) * | 2012-06-19 | 2012-09-26 | 山西双鹰动物药业有限公司 | 治疗猪蓝耳病的中药组合物 |
-
2014
- 2014-08-11 CN CN201410391670.0A patent/CN104173628B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101112446A (zh) * | 2007-08-10 | 2008-01-30 | 邓世平 | 猪蓝耳病的治疗配方、制作方法及其药液使用方法 |
CN101869220A (zh) * | 2010-06-07 | 2010-10-27 | 浙江省农业科学院 | 防控猪高热综合征的中草药饲料添加剂 |
CN102688417A (zh) * | 2012-06-19 | 2012-09-26 | 山西双鹰动物药业有限公司 | 治疗猪蓝耳病的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN104173628A (zh) | 2014-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106039248A (zh) | 一种治疗猪的各种腹泻的中药组方 | |
CN111481618A (zh) | 一种具有预防、治疗或辅助治疗非洲猪瘟功效的中药组合物 | |
CN103394053A (zh) | 一种防治仔猪黄、白痢的中药组合物及其制备和应用 | |
CN104147327A (zh) | 一种用于仔猪细菌性痢疾的药物制剂 | |
CN104173628B (zh) | 一种抗猪免疫抑制的中药组合物 | |
CN102973702B (zh) | 一种用于治疗仔猪黄白痢的复方中药组合物及其制备方法 | |
CN103202908B (zh) | 预防和治疗大肠杆菌病的中草药饲料添加剂 | |
CN102755552B (zh) | 预防猪瘟病的中药 | |
CN104147190A (zh) | 一种治疗羔羊痢疾的中药组合物及其制备方法 | |
CN101342275B (zh) | 一种防治鸡曲霉菌病的药物 | |
CN106359994A (zh) | 仔猪饲料 | |
CN104208247B (zh) | 一种防治毛皮动物病毒性疾病的中药复合制剂 | |
CN105012673A (zh) | 一种防治家畜霉菌毒素中毒的中药及其制备方法 | |
CN105641260A (zh) | 治疗仔猪水肿病的中药组合物及其制备方法 | |
CN103800464B (zh) | 一种治疗仔猪黄白痢的中药组合物 | |
CN102526655B (zh) | 一种用于动物健胃驱虫的药物 | |
CN104367670A (zh) | 一种用于防治仔猪细菌性肠炎的中药颗粒剂及其制备方法 | |
CN104524291A (zh) | 制备用于猪瘟的药物制剂的方法 | |
CN101342351B (zh) | 一种防治禽大肠杆菌病的药物 | |
CN110354194A (zh) | 用于预防和治疗猪支原体肺炎的中药组合物及其制备方法 | |
CN114939135B (zh) | 一种中药组合物在制备治疗猪肺热咳喘药物中的应用 | |
CN105250825A (zh) | 一种治疗和预防畜禽及毛皮动物胃肠炎的中药组合物 | |
CN104147328A (zh) | 一种用于仔猪黄白痢的药物组合物及其制备方法 | |
CN106729080A (zh) | 一种防治猪蓝耳病的中药组合物及其制备方法 | |
CN104288240B (zh) | 一种抗病毒口服液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181204 Address after: 546500 No. 6 Guangyuan Road, Heshan Industrial Transition Park, Laibin City, Guangxi Zhuang Autonomous Region Patentee after: Guangxi Nongda Kangyuan Biopharmaceutical Co.,Ltd. Address before: 530423 Daning Village, Wangling Town, Binyang County, Nanning City, Guangxi Zhuang Autonomous Region Patentee before: BINYANG COUNTY WANGLING TOWN LIANGJUN GOOSE FARM |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171027 |